Serologic diagnosis of inflammatory bowel disease (ASCA and ANCA): Evaluation of 70 cases;Diagnóstico sorológico de doença inflamatória intestinal (ASCA e ANCA): Avaliação de 70 casos

GED - Gastrenterologia Endoscopia Digestiva

Volumn 20, Issue 2, 2001, Pages 41-42

  Steinwurz, F ^a   Scheinberg, M A ^a  

^a NONE   (Brazil)

Author keywords

ASCA and ANCA; Inflammatory bowel disease

Indexed keywords

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; ULCERATIVE COLITIS;

EID: 0034971258     PISSN: 01017772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. The clinical utility of ANCA positivity
2. Antibodies to Saccharomyces cerevisae in patients with Crohn's disease and their possible pathogenic importance
3. Are ASCA and pANCA useful in indeterminate colitis? A prospective follow-up study
4. Specificity of anticytoplasmic neutrophil antibody
5. Pathogenesis of inflammatory bowel disease: Involving concepts
6. On the etiology of Crohn's disease
7. Serological diagnosis of inflammatory bowel disease
8. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)
9. Autoanticorpos e doenc̃a celiaca
10. Anticorpos anticitoplasma de neutrófilos (ANCA)
11. How and why should we detect ANCA?
12. Medical therapy for inflammatory bowel disease
13. Antineutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): A new seromarker for inflammatory bowel disease and associated disorders